Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 7/2019

01-07-2019 | Letter to the Editor

Reply to letter to the editor: “clinical evaluation of ureteral pseudodiverticulosis”

Authors: Matthew A. Morgan, Hanna M. Zafar, Nicholas Papanicolaou, Parvati Ramchandani

Published in: Abdominal Radiology | Issue 7/2019

Login to get access

Excerpt

We thank Dr. Yorita for his interest in our article investigating the association between ureteral pseudodiverticulosis and urothelial cell carcinoma [1]. As to the question of accumulation of cases in the study, it was a retrospective review of sequential patients with ureteral pseudodiverticulosis as described on imaging reports between January 2002 and Jan 2010, as described in the methods section of the article. No pseudodiverticulum was larger than 4 mm in size. …
Literature
1.
Morgan MA, Chua WY, Zafar HM, Papanicolaou N, Ramchandani P (2019) Ureteral pseudodiverticulosis and urothelial cell carcinoma: rethinking the association. Abdom Radiol (NY) 44:234-238.CrossRef
2.
Wasserman NF, Posalaky IP, Dykoski R (1988) The pathology of ureteral pseudodiverticulosis. Invest Radiol 23:592-598.CrossRefPubMed
3.
Spalluto LB, Woodfield CA (2009) Ureteral pseudodiverticulosis: a unique case diagnosed by multidetector computed tomography. J Comput Assist Tomogr 33:286-287.CrossRef
4.
Kawashima A, Vrtiska TJ, LeRoy AJ, Hartman RP, McCollough CH, King BF. CT urography. (2004) Radiographics: a review publication of the Radiological Society of North America, Inc. 24 Suppl 1: S35-54; discussion S55-8.
Metadata
Title
Reply to letter to the editor: “clinical evaluation of ureteral pseudodiverticulosis”
Authors
Matthew A. Morgan
Hanna M. Zafar
Nicholas Papanicolaou
Parvati Ramchandani
Publication date
01-07-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02040-0

Other articles of this Issue 7/2019

Abdominal Radiology 7/2019 Go to the issue

Review

Performance of ultrasound for detection of transjugular intrahepatic portosystemic shunt dysfunction: a meta-analysis

Interventional Radiology

Using principal component analysis for the prediction of tumor response to transarterial chemoembolization

Review

MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls

Practice

Single institutional experience with initial ultrasound followed by computed tomography or magnetic resonance imaging for acute appendicitis in adults

Classics in Abdominal Radiology

The stalk-of-corn sign of ureter

Interventional Radiology

Body composition changes after left gastric artery embolization in overweight and obese individuals
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits